Advertisement

Designing, Reporting, and Interpreting Clinical Research Studies About Treatments for Pain: Evidence-Based Medicine

  • Nisheeth Pandey
  • Joseph Park
  • Sukdeb Datta
Chapter

Abstract

A thorough understanding of evidence-based medicine is a requirement for any clinician, especially those in rapidly developing specialties such as pain medicine. This understanding is not only important to guide clinical practice, but also to empower active contribution to the body of evidence that is required to justify reimbursements for interventions.

Keywords

Evidence-based medicine Trial design Placebo controlled Randomized Bias CONSORT SPIRIT IMMPACT ACTTION 

References

  1. 1.
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2.CrossRefGoogle Scholar
  2. 2.
    Vavken P, Ganal-Antonio AKB, Shen FH, Chapman JR, Samartzis D. Fundamentals of clinical outcomes assessment for spinal disorders: study designs, methodologies, and analyses. Global Spine J. 2015;5(2):156–64.CrossRefGoogle Scholar
  3. 3.
    World Health Organization. n.d. Retrieved January 17, 2017, from http://www.who.int/ictrp/en/.
  4. 4.
    IOM (Institute of Medicine). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011.Google Scholar
  5. 5.
    Katz N. Methodological issues in clinical trials of opioids for chronic pain. Neurology. 2005;65(12 Suppl 4):S32–49.CrossRefGoogle Scholar
  6. 6.
    XenoPort, Inc. Phase II results for GSK1838262 (XP13512) reported for neuropathic pain associated with diabetic peripheral neuropathy; 2009.Google Scholar
  7. 7.
    Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18(6):355–65.CrossRefGoogle Scholar
  8. 8.
    Dworkin RH, et al. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain. 2011;152(3 Suppl):S107–15.CrossRefGoogle Scholar
  9. 9.
    Hrobjartsson A, Gotzsche P. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;(1):CD003974.Google Scholar
  10. 10.
    Quessy SN, Rowbotham MC. Placebo response in neuropathic pain trials. Pain. 2008;138:479–83.CrossRefGoogle Scholar
  11. 11.
    Schmader KE, et al. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc. 2010;85(3 Suppl):S26–32.CrossRefGoogle Scholar
  12. 12.
    Humphreys K, Blodgett JC, Roberts LW. The exclusion of people with psychiatric disorders from medical research. J Psychiatr Res. 2015;70:28–32.CrossRefGoogle Scholar
  13. 13.
    Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain. 2005;115:284–95.CrossRefGoogle Scholar
  14. 14.
    Kim Y. Missing data handling in chronic pain trials. J Biopharm Stat. 2011;21(2):311–25.CrossRefGoogle Scholar
  15. 15.
    Molenberghs G, Kenward MG. Missing data in clinical studies. Chichester, UK: John Wiley & Sons, Ltd; 2007.CrossRefGoogle Scholar
  16. 16.
    National Research Council. The prevention and treatment of missing data in clinical trials. Washington, DC: The National Academies Press; 2010.Google Scholar
  17. 17.
    IOM (Institute of Medicine). Transforming clinical research in the United States: challenges and opportunities. Washington, DC: The National Academies Press; 2010.Google Scholar
  18. 18.
    Liu KS, Snavely DB, Ball WA, Lines CR, Reines SA, Potter WZ. Is bigger better for depression trials? J Psychiatr Res. 2008;42:622–30.CrossRefGoogle Scholar
  19. 19.
    Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11:MR000030.PubMedGoogle Scholar
  20. 20.
    Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.CrossRefGoogle Scholar
  21. 21.
    Dworkin RH, et al. Research design considerations for confirmatory chronic pain trials: IMMPACT recommendations. Pain. 2010;149(2):177–93.CrossRefGoogle Scholar
  22. 22.
    Dworkin RH, et al. A standard database format for clinical trials of pain treatments. Pain. 2013;154(1):11–4.CrossRefGoogle Scholar
  23. 23.
    Manchikanti L, Hirsch JA, Cohen SP, Heavner JE, Falco FJ, Diwan S, et al. Assessment of methodologic quality of randomized trials of interventional techniques: development of an interventional pain management specific instrument. Pain Physician. 2014;17:E263–90.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nisheeth Pandey
    • 1
  • Joseph Park
    • 2
  • Sukdeb Datta
    • 3
  1. 1.Pain ManagementFayette County Memorial HospitalWashington Court HouseUSA
  2. 2.Department of AnesthesiologyIcahn School of Medicine at Mount SinaiNew YorkUSA
  3. 3.Department of AnesthesiologyMount Sinai Medical CenterNew YorkUSA

Personalised recommendations